NCT00350103View on ClinicalTrials.gov

A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

551

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 29, 2007

Study Completion Date

June 29, 2007

Conditions
Painful Diabetic Neuropathy
Interventions
DRUG

SPM 929

"* Pharmaceutical form: Immediate release film-coated tablets~* Concentration: 50mg/ 100mg~* Route of administration: Oral use"

DRUG

Placebo

"* Pharmaceutical form: Immediate release film-coated tablets~* Route of administration: Oral use"

Trial Locations (1)

Unknown

Monheim

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
collaborator

SCHWARZ BIOSCIENCES GmbH - Part of UCB Group

UNKNOWN

lead

UCB Pharma

INDUSTRY